company background image
SMFR

Sema4 Holdings NasdaqGS:SMFR Stock Report

Last Price

US$0.89

Market Cap

US$337.0m

7D

3.9%

1Y

-87.7%

Updated

03 Oct, 2022

Data

Company Financials +
SMFR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health3/6
Dividends0/6

SMFR Stock Overview

Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data.

Sema4 Holdings Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sema4 Holdings
Historical stock prices
Current Share PriceUS$0.89
52 Week HighUS$9.18
52 Week LowUS$0.83
Beta0
1 Month Change-12.35%
3 Month Change-38.95%
1 Year Change-87.65%
3 Year Changen/a
5 Year Changen/a
Change since IPO-90.97%

Recent News & Updates

Aug 26

Sema4 names Kevin Feeley as CFO

Sema4 (NASDAQ:SMFR) has appointed healthcare industry veteran Kevin Feeley as CFO. Feeley has over 20 years of finance and accounting leadership experience in the healthcare, pharmaceutical, and diagnostics sectors. He has held the roles of Senior Vice President of Operations and Head of GeneDx at Sema4 since May 2022. Earlier this month, Sema4 was downgraded at Jefferies due to Q2 miss and guidance cut

Aug 20
Things Look Grim For Sema4 Holdings Corp. (NASDAQ:SMFR) After Today's Downgrade

Things Look Grim For Sema4 Holdings Corp. (NASDAQ:SMFR) After Today's Downgrade

Market forces rained on the parade of Sema4 Holdings Corp. ( NASDAQ:SMFR ) shareholders today, when the analysts...

Aug 19
Sema4 Holdings Corp. (NASDAQ:SMFR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Sema4 Holdings Corp. (NASDAQ:SMFR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

As you might know, Sema4 Holdings Corp. ( NASDAQ:SMFR ) last week released its latest quarterly, and things did not...

Shareholder Returns

SMFRUS HealthcareUS Market
7D3.9%2.1%1.0%
1Y-87.7%12.2%-20.0%

Return vs Industry: SMFR underperformed the US Healthcare industry which returned 7.7% over the past year.

Return vs Market: SMFR underperformed the US Market which returned -23.2% over the past year.

Price Volatility

Is SMFR's price volatile compared to industry and market?
SMFR volatility
SMFR Average Weekly Movement16.4%
Healthcare Industry Average Movement7.9%
Market Average Movement6.8%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: SMFR is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 16% a week.

Volatility Over Time: SMFR's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20201,200Katherine Stuelandhttps://www.sema4.com

Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing.

Sema4 Holdings Corp. Fundamentals Summary

How do Sema4 Holdings's earnings and revenue compare to its market cap?
SMFR fundamental statistics
Market CapUS$336.98m
Earnings (TTM)-US$170.09m
Revenue (TTM)US$191.09m

1.8x

P/S Ratio

-2.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SMFR income statement (TTM)
RevenueUS$191.09m
Cost of RevenueUS$225.87m
Gross Profit-US$34.78m
Other ExpensesUS$135.32m
Earnings-US$170.09m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.45
Gross Margin-18.20%
Net Profit Margin-89.01%
Debt/Equity Ratio1.7%

How did SMFR perform over the long term?

See historical performance and comparison